Hematology
Hematopoietic Stem Cell Transplantation
0
Pipeline Programs↗
19
Active Trials↗
7
Companies Involved↗
Hematopoietic Stem Cell Transplantation is an early-stage landscape with 0 programs across 7 companies. The most active players are Kiadis Pharma, Jasper Therapeutics, Inc., The Korean Society of Pediatric Hematology Oncology.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
67
clinical trials
Completed22 · 33%
Unknown status21 · 31%
Recruiting11 · 16%
Terminated5 · 7%
Active, not recruiting4 · 6%
Not yet recruiting3 · 4%
Other1 · 1%
Clinical Trials
Trial Activity
67 trials
Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation
Recruiting·—·Phase 1·NCT03378102·20 enrolled
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
Recruiting·—·Phase 1·NCT06138587·15 enrolled
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
Active, not recruiting·PPediatric Transplantation & Cellular Therapy Consortium·Phase 1/2·NCT03475212·52 enrolled
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
Active, not recruiting·—·Phase 2·NCT04060277·7 enrolled
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
Active, not recruiting·—·Phase 1·NCT03180216·32 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)